Hericium erinaceus 'Yamabushitake'

Hericium erinaceus 'Yamabushitake' is a medicinal mushroom whose primary bioactive compounds, hericenones and erinacines, stimulate nerve growth factor (NGF) synthesis in the brain. This NGF upregulation supports neuronal regeneration and synaptic plasticity, underpinning its cognitive and neuroprotective effects.

Origin & History

Hericium erinaceus 'Yamabushitake' is a tooth fungus that grows on hardwood tree trunks, characterized by its distinctive dangling spines longer than 1 centimeter. Commercial preparations typically involve polysaccharide extraction from fruiting bodies or mycelium (HERP and HECP extracts), as well as isolation of specific bioactive diterpenoid compounds including erinacines and hericenones.

Historical & Cultural Context

Hericium erinaceus has been used in Traditional Chinese Medicine for centuries, recognized for its immunomodulatory properties from polysaccharides. In TCM, it is valued as an adaptogen for reducing depression, anxiety, insomnia, and concentration deficits, particularly in elderly individuals, students, and professionals under stress.

Health Benefits

• Cognitive enhancement: Double-blind placebo-controlled trial (n=30) showed marked improvement in mild cognitive impairment on the Hasegawa Dementia Scale (moderate evidence)
• Gastroprotection: Animal studies demonstrated significant reduction in ethanol-induced and pylorus-ligated gastric ulcers at 200 mg/kg via anti-inflammatory mechanisms (preliminary evidence)
• Neuroprotection: Reduced brain infarction by 22-44% in animal stroke models at 50-300 mg/kg doses, mediated by cytokine reduction (preliminary evidence)
• Nerve regeneration: Stimulates nerve growth factor (NGF) synthesis and neurite outgrowth through erinacine compounds (preliminary evidence)
• Antioxidant activity: Most potent in vitro inhibitor of LDL oxidation and HMG Co-A reductase among studied mushrooms (preliminary evidence)

How It Works

Erinacines (diterpenes found in the mycelium) cross the blood-brain barrier and directly stimulate NGF mRNA expression in astrocytes and hippocampal neurons, while hericenones (aromatic compounds in the fruiting body) promote NGF secretion via PKA/CREB signaling pathways. Polysaccharide fractions, particularly beta-1,3/1,6-glucans, modulate gut mucosal immunity and inhibit H. pylori adhesion, contributing to gastroprotection. Additionally, erinacine A has been shown to upregulate BDNF and suppress pro-inflammatory cytokines including TNF-α and IL-1β through NF-κB pathway inhibition.

Scientific Research

A double-blind, placebo-controlled trial with 30 Japanese adults aged 50-80 with mild cognitive impairment demonstrated significant cognitive improvements after 16 weeks of 750mg daily supplementation, though effects diminished within 4 weeks of cessation. Animal studies showed dose-dependent neuroprotective effects in stroke models and gastroprotective properties. Note: The research dossier does not provide specific PubMed PMIDs for these trials.

Clinical Summary

A double-blind, placebo-controlled trial (n=30, 16 weeks, 1 g/day fruiting body powder taken three times daily) demonstrated statistically significant improvements in Hasegawa Dementia Scale scores in adults with mild cognitive impairment, with scores declining after cessation of supplementation, suggesting effect dependency. Animal studies using ethanol-induced and pylorus-ligated models showed significant reductions in gastric ulcer index scores, attributed to polysaccharide-mediated mucosal protection and antioxidant activity. Evidence for cognitive benefits in otherwise healthy adults remains limited to preclinical models and small pilots; the mild cognitive impairment trial represents the strongest human evidence currently available. Larger, longer-duration RCTs are needed before definitive clinical recommendations can be made.

Nutritional Profile

Hericium erinaceus (Lion's Mane / Yamabushitake) contains a well-characterized nutritional and bioactive compound profile. Macronutrients (per 100g dry weight): protein 22-35g (containing all essential amino acids; glutamic acid and aspartic acid predominant), total carbohydrates 40-60g (including polysaccharides 35-50g), dietary fiber 15-25g (predominantly beta-glucans), fat 2-5g (linoleic acid as primary fatty acid ~70-80% of fat fraction). Key bioactive compounds: Hericenones (C-G; aromatic compounds found in fruiting body at approximately 0.03-0.5mg/g dry weight) — lipid-soluble, good oral bioavailability, cross blood-brain barrier; Erinacines (A-I; cyathane diterpenoids found primarily in mycelium at 0.1-1.2mg/g dry weight) — notably erinacine A is the most studied NGF-stimulating compound; Beta-1,3/1,6-glucans (approximately 15-30% of dry weight) — immunomodulatory polysaccharides with moderate bioavailability, enhanced by hot water extraction; Hericerins and isoindolinones (minor aromatic compounds, trace quantities <0.1mg/g). Micronutrients: potassium ~400-500mg/100g dry, phosphorus ~800-1000mg/100g dry, zinc ~2-3mg/100g dry, selenium ~0.2-0.5mcg/g dry, ergosterol (provitamin D2) ~1-3mg/g dry (converted to vitamin D2 upon UV exposure). Vitamins: B1 (thiamine) ~0.2mg/100g, B2 (riboflavin) ~0.4mg/100g, B3 (niacin) ~6-8mg/100g. Bioavailability notes: Hot water extraction significantly improves beta-glucan and polysaccharide bioavailability; erinacines are better extracted via ethanol/methanol; dual-extraction products preserve both fractions. Fruiting body vs. mycelium matter significantly — erinacines predominantly in mycelium; hericenones in fruiting body. Myceliated grain products may dilute active compound concentrations substantially depending on extraction ratio.

Preparation & Dosage

Clinical trial dosage: 250 mg tablets (96% dry powder) taken three times daily (750 mg total) for cognitive support. Animal model dosages: 50-300 mg/kg for neuroprotection, 200 mg/kg for gastroprotection. Standardization metrics for commercial extracts not specified in available research. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Bacopa monnieri, Ginkgo biloba, Phosphatidylserine, Omega-3 fatty acids, B-complex vitamins

Safety & Interactions

Yamabushitake is generally well tolerated; the clinical trial (n=30) reported no serious adverse events, though rare cases of skin rash and contact dermatitis have been documented, likely from beta-glucan immune activation. Individuals with mushroom allergies or autoimmune conditions (e.g., multiple sclerosis, lupus, rheumatoid arthritis) should exercise caution, as immunomodulatory beta-glucans may theoretically exacerbate immune activity. No well-documented drug interactions exist, but additive effects are plausible with chemotherapy agents, immunosuppressants, and anticoagulants due to platelet aggregation inhibition observed in vitro. Safety data in pregnant or breastfeeding women are absent, so use is not recommended during these periods.